Physician
Bernhardt, Peter
Bernhardt, Peter was paid $2.21M by Medicaid between Jan 2018 and Sep 2024, across 116 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 11% of everything it billed.
33Billing provider infoBERNHARDT, PETER
ELK GROVE VILLAGE, IL 60007
ELK GROVE VILLAGE, IL 60007
33aNPI1619997962assigned 07/20/2006
33bProvider typeHematology (Pathology) Physician
28Total paid$2.21M
24GClaims403,801
24DCodes billed116
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Hematology (Pathology) Physician providers in Illinois
Rank by total paid#2 of 16
Median peer was paid$18K
This provider vs. median123×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 50,467 | $286K | |
| 2019 | 65,973 | $347K | |
| 2020 | 66,647 | $332K | |
| 2021 | 68,681 | $398K | |
| 2022 | 63,840 | $382K | |
| 2023 | 63,165 | $342K | |
| 2024incomplete | 25,028 | $121K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 11% | 45,515 | 27,595 | $236K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.7% | 57,799 | 30,787 | $170K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7.3% | 6,714 | 5,235 | $160K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5.2% | 3,133 | 2,892 | $114K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 4.3% | 2,697 | 2,270 | $95K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3.8% | 502 | 435 | $83K |
| 83735 | 3.7% | 21,330 | 9,707 | $82K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.5% | 18,430 | 7,295 | $77K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3.3% | 568 | 525 | $72K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2.9% | 277 | 248 | $63K |
| 87040 | 2.5% | 5,175 | 3,403 | $55K | |
| 82947 | 2.5% | 15,921 | 5,396 | $55K |
104 more codes
| 84484 | 2.4% | 12,383 | $52K | |
| 85027 | 2.0% | 15,204 | $43K | |
| 83880 | 1.9% | 3,952 | $42K | |
| 82805 | 1.8% | 1,794 | $41K | |
| 85730 | 1.8% | 11,086 | $40K | |
| 87641 | 1.7% | 1,641 | $37K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.6% | 1,626 | $36K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.5% | 551 | $33K |
| 86850 | 1.5% | 11,153 | $33K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.4% | 4,057 | $32K |
| 86901 | 1.4% | 13,354 | $31K | |
| 85610 | 1.2% | 13,882 | $28K | |
| 83605 | 1.2% | 4,911 | $27K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.0% | 4,514 | $23K |
| 86900 | 1.0% | 13,359 | $23K | |
| 83690 | 1.0% | 6,740 | $23K | |
| 81001 | <1% | 14,794 | $21K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 529 | $21K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,608 | $21K |
| 81025 | <1% | 9,006 | $18K | |
| 82330 | <1% | 2,115 | $18K | |
| 80061 | Lipid panel | <1% | 4,758 | $16K |
| 87186 | <1% | 2,421 | $16K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,456 | $15K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 563 | $13K |
| 85379 | <1% | 3,376 | $13K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,014 | $12K |
| 86920 | <1% | 1,904 | $10K | |
| 87486 | <1% | 433 | $10K | |
| 86140 | <1% | 4,096 | $10K | |
| 87581 | <1% | 433 | $10K | |
| 84100 | <1% | 3,579 | $9K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 281 | $9K |
| 83655 | <1% | 1,435 | $9K | |
| 84439 | <1% | 1,912 | $8K | |
| 83013 | <1% | 605 | $8K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 333 | $8K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 328 | $7K |
| 82803 | <1% | 771 | $6K | |
| 84702 | <1% | 1,380 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 103 | $6K |
| 84030 | <1% | 2,173 | $6K | |
| 82607 | <1% | 858 | $5K | |
| 82728 | <1% | 1,093 | $5K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 128 | $4K |
| 82570 | <1% | 1,774 | $4K | |
| 87205 | <1% | 2,235 | $4K | |
| 84132 | <1% | 2,839 | $4K | |
| 80069 | <1% | 901 | $4K | |
| 85652 | <1% | 2,859 | $4K | |
| 81003 | <1% | 3,469 | $4K | |
| 82248 | <1% | 1,646 | $4K | |
| 84703 | <1% | 991 | $4K | |
| 87070 | <1% | 1,084 | $3K | |
| 83550 | <1% | 752 | $3K | |
| 85018 | <1% | 2,957 | $3K | |
| 87081 | <1% | 1,015 | $3K | |
| 86880 | <1% | 977 | $3K | |
| 83615 | <1% | 1,034 | $3K | |
| 83540 | <1% | 874 | $3K | |
| 84550 | <1% | 1,364 | $3K | |
| 85014 | <1% | 2,523 | $3K | |
| 80202 | <1% | 369 | $2K | |
| 82550 | <1% | 772 | $2K | |
| 82247 | <1% | 849 | $2K | |
| 82746 | <1% | 258 | $1K | |
| 84156 | <1% | 1,248 | $1K | |
| 82077 | <1% | 132 | $1K | |
| 82810 | <1% | 278 | $1K | |
| 84295 | <1% | 685 | $1K | |
| 88307 | <1% | 15 | $1K | |
| 88342 | <1% | 69 | $1K | |
| 87420 | <1% | 131 | $1K | |
| 86592 | <1% | 494 | $973.73 | |
| 82962 | <1% | 392 | $891.32 | |
| 85347 | <1% | 285 | $789.93 | |
| 87806 | <1% | 75 | $737.25 | |
| 82435 | <1% | 456 | $734.87 | |
| 85384 | <1% | 239 | $669.93 | |
| 87634 | <1% | 16 | $390.00 | |
| 83021 | <1% | 63 | $368.29 | |
| 86480 | <1% | 12 | $311.64 | |
| 84145 | <1% | 123 | $250.44 | |
| 80076 | <1% | 73 | $244.85 | |
| 87449 | <1% | 22 | $172.48 | |
| 82140 | <1% | 39 | $170.43 | |
| 87340 | <1% | 25 | $168.75 | |
| 86039 | <1% | 30 | $149.80 | |
| 85651 | <1% | 55 | $125.91 | |
| 87045 | <1% | 19 | $116.85 | |
| 86038 | <1% | 14 | $109.34 | |
| 87210 | <1% | 41 | $109.33 | |
| 86870 | <1% | 12 | $107.56 | |
| 85007 | <1% | 46 | $82.42 | |
| 86308 | <1% | 31 | $74.40 | |
| 87075 | <1% | 13 | $73.09 | |
| 84481 | <1% | 12 | $68.80 | |
| 83014 | <1% | 15 | $53.22 | |
| 84300 | <1% | 17 | $36.04 | |
| 82043 | <1% | 14 | $25.36 | |
| 87046 | <1% | 22 | $25.20 | |
| 82009 | <1% | 12 | $18.96 | |
| 80050 | General health panel | <1% | 211 | $10.65 |
| 87077 | 0% | 70 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.